Description and Brand Names

Drug information provided by: Merative, Micromedex®

US Brand Name

  1. Zejula

Descriptions


Niraparib is used as first-line maintenance treatment in patients with advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. It is also used as maintenance treatment in patients with recurrent (cancer that comes back) ovarian cancer, fallopian tube cancer, or primary peritoneal cancer with a certain type of inherited (germline) abnormal BRCA gene. Your doctor will test for the presence of this gene (deleterious or suspected deleterious germline BRCA gene). This medicine is used in patients who have had received platinum-based cancer medicines.

This medicine is available only with your doctor's prescription.

This product is available in the following dosage forms:

  • Tablet

From Mayo Clinic to your inbox

Sign up for free and stay up to date on research advancements, health tips, current health topics, and expertise on managing health. Click here for an email preview.

To provide you with the most relevant and helpful information, and understand which information is beneficial, we may combine your email and website usage information with other information we have about you. If you are a Mayo Clinic patient, this could include protected health information. If we combine this information with your protected health information, we will treat all of that information as protected health information and will only use or disclose that information as set forth in our notice of privacy practices. You may opt-out of email communications at any time by clicking on the unsubscribe link in the e-mail.

Portions of this document last updated: Feb. 01, 2024

Copyright: © Merative US L.P. 1973, 2024. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.